Rate My Professor Mercedes Burnside

Her research centers on type 1 diabetes management in children, encompassing automated insulin delivery systems, continuous glucose monitoring, open-source technologies, and health equity particularly for Māori children and adolescents. Notable publications include 'Emergent inequity of glycaemic metrics for Māori children with type 1 diabetes is negated by early use of continuous glucose monitoring' (2024, New Zealand Medical Journal), 'Children and adolescents with type 1 diabetes in Aotearoa New Zealand: An online survey of workforce and outcomes 2021' (2024, Journal of Paediatrics & Child Health), 'Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial' (2023), 'Prevalence and incidence of type 1 diabetes in children aged 0–14 years old in New Zealand in 2021' (2023, Journal of Paediatrics and Child Health), 'New tubeless, automated insulin pump improves HbA1c and time in pre-defined glucose range' (2022, The Journal of Pediatrics), and 'Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine' (2019, Journal of Diabetes Science and Technology). She holds a Clinical Research Training Fellowship for the CREATE Trial investigating community-derived automated insulin delivery.